Chemicals

((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate

We are ((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate CAS:13007-50-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate

CAS.NO:13007-50-6

Synonyms:((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate

methyl 5-tosyl-5-deoxy-2,3-O-isopropyliden-D-ribofuranoside

1-O-methyl-2,3-O-(1-methylethylidene)-5-O-(4-methylbenzenesulfonyl)-D-ribofuranoside

5-O-p-toluenesulfonyl-2,3-O-isopropylidene-β-D-ribofuranoside

1-O-methyl-2,3-O-(1-methylethylidene)-5-O-(4-methylbenzene sulfonyl)-D-ribofuranoside

methyl 5-(4-methylbenzenesulfonate)-2,3-O-(1-methylethylidene)-D-ribofuranoside

Physical and Chemical Properties:

Molecular Formula C16H22O7S

Molecular Weight 358.40700

Specification:

Appearance:White crystalline powder

Assay:≥98.0%

Packing:25 kg/drum, can also be packaged according to customer requirements

Storage:Store in a cool, ventilated place

Application:Intermediate of Capecitabine(CAS:154361-50-9).

((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate

Related News: The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.110-53-2 The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine CAS:3159-07-7 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.

Product Name
1-Bromo-2,3-Difluorobenzene Cas:38573-88-5	View Details
Emamectin benzoate Cas:155569-91-8	View Details
Ethyl-2-ethoxy-1-[[(2′-cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-carboxylate Cas:139481-41-7	View Details